2017 ASH MHM: Focus on Leukemia – Anjali Advani, MD
578 views · Published 24 March 2017 · 1:30 · Indexed 20 September 2026
Channel: American Society of Hematology · 2017 · Nonprofits & Activism
Anjali Advani, MD, discusses exciting updates in leukemia, including newly approved drugs (blinatumomab) and drugs in the pipeline (inotuzumab). Leukemia is one of the core malignancies covered at the ASH Meeting on Hematologic Malignancies (MHM), which is structured in a “How I Treat” format that provides an ideal learning experience for physicians who treat leukemia. The meeting’s expert speakers discuss specific patient cases, present cutting-edge scientific data, and provide insight into how new treatments can be incorporated upfront. Learn more about the ASH Meeting on Hematologic Malignancies at http://www.hematology.org/Malignancies/
More from this channel
-
1:52
Ron Reagan Accepts ASH Award - Stem Cell Research
-
3:56
ASH and the Reagans Support Stem Cell Research
-
6:35
ASH News TV: Late Breaking Abstracts & ASH SAP 5th Addition
-
2:34
ASH State-of-the-Art Symposium
-
3:42
CLL-IPI: A New and Improved Staging System for CLL?
-
4:44
About the ASH Clinical Research Training Institute
-
6:56
Joseph M. Connors, MD: Optimizing Therapy, Minimizing Toxicity in Hodgkin Lymphoma
-
1:30
Meet the Co-Chairs: 2018 ASH Meeting on Lymphoma Biology